BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12237221)

  • 1. Replacement of active-site cysteine-436 by serine converts cytochrome P450 2B4 into an NADPH oxidase with negligible monooxygenase activity.
    Vatsis KP; Peng HM; Coon MJ
    J Inorg Biochem; 2002 Sep; 91(4):542-53. PubMed ID: 12237221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abolition of oxygenase function, retention of NADPH oxidase activity, and emergence of peroxidase activity upon replacement of the axial cysteine-436 ligand by histidine in cytochrome P450 2B4.
    Vatsis KP; Peng HM; Coon MJ
    Arch Biochem Biophys; 2005 Feb; 434(1):128-38. PubMed ID: 15629116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4.
    Vaz AD; Pernecky SJ; Raner GM; Coon MJ
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4644-8. PubMed ID: 8643457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome b5 inhibits electron transfer from NADPH-cytochrome P450 reductase to ferric cytochrome P450 2B4.
    Zhang H; Hamdane D; Im SC; Waskell L
    J Biol Chem; 2008 Feb; 283(9):5217-25. PubMed ID: 18086668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key residues in rabbit liver microsomal cytochrome P450 2B4: importance in interactions with NADPH-cytochrome P450 reductase.
    Lehnerer M; Schulze J; Achterhold K; Lewis DF; Hlavica P
    J Biochem; 2000 Jan; 127(1):163-9. PubMed ID: 10731679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome b5 increases the rate of product formation by cytochrome P450 2B4 and competes with cytochrome P450 reductase for a binding site on cytochrome P450 2B4.
    Zhang H; Im SC; Waskell L
    J Biol Chem; 2007 Oct; 282(41):29766-76. PubMed ID: 17693640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4-1A2 complex with a high affinity for NADPH-cytochrome P450 reductase.
    Backes WL; Batie CJ; Cawley GF
    Biochemistry; 1998 Sep; 37(37):12852-9. PubMed ID: 9737863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional characterization of a cytochrome P450 2B4 F429H mutant with an axial thiolate-histidine hydrogen bond.
    Yang Y; Zhang H; Usharani D; Bu W; Im S; Tarasev M; Rwere F; Pearl NM; Meagher J; Sun C; Stuckey J; Shaik S; Waskell L
    Biochemistry; 2014 Aug; 53(31):5080-91. PubMed ID: 25029089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Self-inactivation of cytochrome P-450 2B4 during catalytic cycle in the monooxygenase reconstituted system].
    Zgoda VG; Karuzina II; Archakov AI
    Vopr Med Khim; 1997; 43(4):217-25. PubMed ID: 9312936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of amino acid residues critical for unique activities of rabbit cytochrome P450 2B5 using hybrid enzymes and reciprocal site-directed mutagenesis with rabbit cytochrome P450 2B4.
    Szklarz GD; He YQ; Kedzie KM; Halpert JR; Burnett VL
    Arch Biochem Biophys; 1996 Mar; 327(2):308-18. PubMed ID: 8619620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. tert-Butylphenylacetylene is a potent mechanism-based inactivator of cytochrome P450 2B4: inhibition of cytochrome P450 catalysis by steric hindrance.
    Zhang H; Lin HL; Walker VJ; Hamdane D; Hollenberg PF
    Mol Pharmacol; 2009 Nov; 76(5):1011-8. PubMed ID: 19720728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interconversion of the androstenedione hydroxylase specificities of cytochromes P450 2B4 and 2B5 upon simultaneous site-directed mutagenesis of four key substrate recognition residues.
    He YQ; Szklarz GD; Halpert JR
    Arch Biochem Biophys; 1996 Nov; 335(1):152-60. PubMed ID: 8914846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase.
    Bridges A; Gruenke L; Chang YT; Vakser IA; Loew G; Waskell L
    J Biol Chem; 1998 Jul; 273(27):17036-49. PubMed ID: 9642268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent assay for riboflavin binding to cytochrome P450 2B4.
    Shumyantseva VV; Bulko TV; Petushkova NA; Samenkova NF; Kuznetsova GP; Archakov AI
    J Inorg Biochem; 2004 Feb; 98(2):365-70. PubMed ID: 14729317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for the inability of an oxygen atom donor ligand to replace the natural sulfur donor heme axial ligand in cytochrome P450 catalysis. Spectroscopic characterization of the Cys436Ser CYP2B4 mutant.
    Perera R; Sono M; Voegtle HL; Dawson JH
    Arch Biochem Biophys; 2011 Mar; 507(1):119-25. PubMed ID: 21147058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Proximal Cysteine Hydrogen Bonding Interaction in Cytochrome P450 2B4 Studied by Cryoreduction, Electron Paramagnetic Resonance, and Electron-Nuclear Double Resonance Spectroscopy.
    Davydov R; Im S; Shanmugam M; Gunderson WA; Pearl NM; Hoffman BM; Waskell L
    Biochemistry; 2016 Feb; 55(6):869-83. PubMed ID: 26750753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cysteine 337 and cysteine 340 in flavoprotein that functions as NADH oxidase from Amphibacillus xylanus studied by site-directed mutagenesis.
    Ohnishi K; Niimura Y; Hidaka M; Masaki H; Suzuki H; Uozumi T; Nishino T
    J Biol Chem; 1995 Mar; 270(11):5812-7. PubMed ID: 7726998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl)imidazole at 1.9-A resolution: insight into the range of P450 conformations and the coordination of redox partner binding.
    Scott EE; White MA; He YA; Johnson EF; Stout CD; Halpert JR
    J Biol Chem; 2004 Jun; 279(26):27294-301. PubMed ID: 15100217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-site mutation (F429H) converts the enzyme CYP 2B4 into a heme oxygenase: a QM/MM study.
    Usharani D; Zazza C; Lai W; Chourasia M; Waskell L; Shaik S
    J Am Chem Soc; 2012 Mar; 134(9):4053-6. PubMed ID: 22356576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli.
    Pernecky SJ; Olken NM; Bestervelt LL; Coon MJ
    Arch Biochem Biophys; 1995 Apr; 318(2):446-56. PubMed ID: 7733676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.